2 Fast-Growing Pharmaceutical Stocks to Buy Now
(NASDAQ: INCY) and TG Therapeutics (NASDAQ: TGTX) are commercial-stage biotech companies that are using blockbuster drugs to fund the growth of their promising pipelines. Incyte is known for its work in Janus kinase (JAK) inhibition, focusing on dermatology, oncology, hematology, inflammation, and autoimmune disorders.TG Therapeutics is focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases.
Both stocks are delivering strong returns. Shares of Incyte are up more than 17% this year, while TG Therapeutics is up nearly 90% so far in 2026.
Here are reasons to buy the pharmaceutical stocks:
Source Fool.com
Incyte Corp. Stock
With 25 Buy predictions and 1 Sell predictions Incyte Corp. is one of the favorites of our community.
As a result the target price of 114 € shows a slightly positive potential of 10.09% compared to the current price of 103.55 € for Incyte Corp..


